*REITERATES ANNUAL AND MID-TERM GUIDANCE
*APPOINTMENT OF CATHERINE VANDENBORRE AS CFO AND HEAD OF THE IBA CORPORATE ENTITY, STARTING 1 JULY 2025
*OUTLOOK 2025: REBIT: AT LEAST EUR 25 MILLION GROUP REBIT SUPPORTED BY POSITIVE REBIT IN PROTON THERAPY
*Q1 EQUIPMENT AND SERVICES BACKLOG AT €1.5 BILLION
*END-Q1 € 9 MILLION POSITIVE NET CASH POSITION
*OUTLOOK 2024-2028: REVENUE NORMALIZED FRONTLOADED GROWTH AT 5-7% CAGR
*ON U.S. TARIFFS: MAINTAINS EXPECTATION OF A LOW TO MEDIUM IMPACT, WITH MITIGATION MEASURES UNDER ASSESSMENT
((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 22-MAY-202504:53:29 GMT